Clinproxy: In general the overall expense of clinical trials depends on a multitude of factors

In an ever growing global market of supply and demand, it remains unimaginable to engage in practices that are ambitiously expensive when there are endless opportunities to utilize more appropriately priced methods which would in turn yield the same results. The overall cost of clinical trials depends on a multitude of factors: study design, sample size, number of clinical sites, equipment used, number of visits, number of lab tests. Depending on the service provider you seek to employ and carry out these processes, the final dollar figure could differ by a factor of three. Hence the overall price of a clinical trial can vary from one extreme to the other. Sponsors need to employ CRO’s that have the capacity to monitor and address the multitude of aspects in a trial to ensure that budgets do not exceed financial limits for the sake of the investigator's ambitions. However, clinical trials are still employed in this manner, with full disregard to the financial pitfalls of inflexible protocols and ideas of clinical scientists. This is what Clinproxy, www.clinproxy.com a CRO (contract research organization), seeks to remedy. Clinproxy offers a all inclusive approach to clinical design and consultation with principle investigators to prevent difficulties in the early stages of clinical development. Patient recruitment practices, which if mismanaged could lead to poor compliance or even worse, excessive patients spread across various trial sites swelling the costs of the trial.